High transcatheter heart valve implantation reduces conduction disturbances after TAVR: JACC
Japan: High transcatheter heart valve (THV) implantation remarkably reduces conduction disturbances after TAVR (transcatheter aortic valve replacement), a recent study published in JACC: Cardiovascular Interventions has shown. However, CT after TAVR revealed a risk for unfavourable coronary access after TAVR and sinus sequestration in TAVR-in-TAVR.
The study showed that high THV implantation versus conventional implantation was associated with a remarkable reduction in pacemaker rates (0% versus 10.8% Evolut; no difference in SAPIEN 3).
Data are scarce regarding the impact of high THV implantation on coronary access after TAVR as evaluated by postimplantation CT (computed tomography). To fill this knowledge gap, Tomoki Ochiai, Department of Cardiology, Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan, and colleagues sought to assess the impact of high THV implantation on coronary access after TAVR.
The study included 258 and 160 patients treated with SAPIEN 3 and Evolut R/PRO/PRO+ THVs, respectively. In the Evolut R/PRO/PRO+ group, the target implantation depth was 1 to 3 mm using the cusp overlap view with commissural alignment technique for the HIT (high implantation technique), whereas, for the conventional implantation technique (CIT), it was 3 to 5 mm using 3-cusp coplanar view. In the SAPIEN 3 group, the HIT employed the radiolucent line-guided implantation, whereas, for the CIT, central balloon marker-guided implantation was used. To analyze coronary accessibility, post-TAVR CT was performed.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.